Global Dengue Virus Diagnostic Tests Market Growth (Status and Outlook) 2023-2029

Global Dengue Virus Diagnostic Tests Market Growth (Status and Outlook) 2023-2029

Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).

LPI (LP Information)' newest research report, the “Dengue Virus Diagnostic Tests Industry Forecast” looks at past sales and reviews total world Dengue Virus Diagnostic Tests sales in 2022, providing a comprehensive analysis by region and market sector of projected Dengue Virus Diagnostic Tests sales for 2023 through 2029. With Dengue Virus Diagnostic Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dengue Virus Diagnostic Tests industry.

This Insight Report provides a comprehensive analysis of the global Dengue Virus Diagnostic Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dengue Virus Diagnostic Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Dengue Virus Diagnostic Tests market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dengue Virus Diagnostic Tests and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dengue Virus Diagnostic Tests.

The global Dengue Virus Diagnostic Tests market size is projected to grow from US$ 3179.6 million in 2022 to US$ 4122.9 million in 2029; it is expected to grow at a CAGR of 3.8% from 2023 to 2029.

United States market for Dengue Virus Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Dengue Virus Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Dengue Virus Diagnostic Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Dengue Virus Diagnostic Tests players cover Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, Wondfo, BTNX, GENESIS, Boson Biotech and Adaltis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Dengue Virus Diagnostic Tests market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test

Segmentation by application
Hospital
Research Institution
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO

Please note: The report will take approximately 2 business days to prepare and deliver.